Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CannAssist International Corp. (CNSC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.50000.0000 (0.00%)
At close: 03:25PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5000
Open0.5000
BidN/A x N/A
AskN/A x N/A
Day's Range0.5000 - 0.5000
52 Week Range0.0600 - 0.9900
Volume100
Avg. Volume709
Market Cap5.708M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0150
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CNSC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANNASSIST INTL CORP
    Analyst Report: Salesforce.com IncSalesforce.com is a cloud-based software-as-a-service customer relationship management or CRM software company. It offers its software through its Sales Cloud, Service Cloud, Marketing Cloud, and Salesforce Platform solutions. The company has expanded its offerings into the mobile, social networking, analytics, and artificial intelligence areas. Salesforce.com sells its software on a subscription basis, both directly and through third-party partners, including systems integrators, consulting firms, and distributors. About 32% of Salesforce.com's revenue comes from outside the U.S. The company was founded in 1999 and went public in June 2004.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast Featuring Mark Palumbo, Founder & CEO of CannAssist International Corp.

    LOS ANGELES, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The Bell2Bell Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The Bell2Bell Podcast delivers informative updates and exclusive interviews with executives operating in fast-moving industries. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist International Corp. (OTCQB: CNSC). As noted in the interview, CannAssist International is a company born on research. “We really saw a lot of stuff coming out in the industry early on where the application of CBD was very good and very promising; however, the reality of how things were being presented didn’t translate that level of performance,” Palumbo said. “Our initial attempts were at enhancing the performance of the CBD molecule … the research focused on making sure that we could make this product and we could make it in large volume. Once the concept was proven, which we did through third-party labs, we could show what properties it had to enhance … the problems that the CBD was having. One was, because of its oil solubility, its bioavailability was limited. The other one … was stability. … We ran an analysis to show we could enhance that quite a bit, and we’ve got a shelf life now of two years.” Palumbo then spoke to CannAssist’s business model, including the decision to take the company public on the OTCQB Venture Market. “The business model was to move on to becoming a public company. … Among the things that we were seeing out in the market were claims that were being made that weren’t necessarily supportable or, from the FDA point of view, legal. So, we decided on the public company model so that we would have absolute transparency. … In addition to the transparency, the other reason for going public was the fundraising opportunities. … We found that would be a more viable way to maintain a level of decision-making ownership of the company and keep it to its visions and, ultimately, its dreams.” To hear the whole episode and subscribe for future episodes, visit: https://podcast.bell2bell.com Palumbo next turned his attention to the company’s technology, which was developed as a product of Xceptor Labs, CannAssist’s technology-focused subsidiary. He noted that the company’s platform is capable of improving the performance of CBD and a host of other oil-soluble active ingredients, including non-CBD cannabinoids, terpenes, essential oils and oil-soluble vitamins. “Xceptor Labs uses a B2B business model,” he explained. “We basically can generate a raw material and customize that raw material. We can sell it to other tech houses … and, of course, for the branded companies, we can do it in such a way that we can customize what they’re looking for and help them make the claims that they seek to make.” “The other side of the business for us is B2C,” Palumbo continued. “We have a brand we call Xceptol. Once we were having the level of success we were with the performance of this product, we really wanted to get it to as many people as we could … to make sure that it was accessible and understandable.” Join InvestorBrandNetwork’s Stuart Smith and Mark Palumbo, founder and CEO of CannAssist International Corp. (OTCQB: CNSC), to hear more about CannAssist’s management team, as well as the company’s milestones in 2020 and goals for 2021. To hear the whole episode and subscribe for future episodes, visit: https://podcast.bell2bell.com The latest installment of The Bell2Bell Podcast continues to reinforce InvestorBrandNetwork’s commitment to the expansion of its robust network of brands, client partners, followers and the growing IBN Podcast Series. For more than 15 years, IBN has leveraged this commitment to provide unparalleled distribution and corporate messaging solutions to 500+ public and private companies. To learn more about IBN’s achievements and milestones via a visual timeline, visit: https://IBN.fm/TimeLine About InvestorBrandNetwork The InvestorBrandNetwork (“IBN”) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients. Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution. For more information on IBN, visit https://www.InvestorBrandNetwork.com. Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: https://IBN.fm/Disclaimer Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements. Corporate Communications InvestorBrandNetwork (IBN)Los Angeles, Californiawww.InvestorBrandNetwork.com310.299.1717 OfficeEditor@InvestorBrandNetwork.com

  • GlobeNewswire

    CannAssist International Xceptol Brand Approved and Included by RangeMe — Increasing SKUs and Providing Access to Over 10,000 Retailers

    NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC) ("CannAssist International" or the "Company") today announces its Xceptol brand approval on the distribution website RangeMe. This week, RangeMe added Xceptol drops and capsules to the Xceptol pain cream products already available on the RangeMe platform, bringing the number of available Xceptol SKUs on the platform to 10, with additional SKUs coming in the first quarter of 2021. RangeMe's broad network creates a significant new revenue source for CannAssist International.      CannAssist CEO Mark Palumbo says:     "This is exciting news for us on many fronts; a process estimated to take weeks was accomplished in a few days – a testament, I feel, to the quality of the Xceptol brand. Also gratifying is being included on the RangeMe website, a significant portal for major retailers to find products for their customers."     About CannAssist International Corp.     CannAssist, the parent company of Xceptor Labs, produces and sells its CiBiDinol technology, formulated using a proprietary process developed by the Company's founder, Mark Palumbo. Research and development aimed at enhancing the bioavailability of oil-soluble molecules resulted in the Company's CiBiDinol technology. CiBiDinol is the driving force behind CannAssist's Xceptol brand of consumable and topical products. Possessing a National Drug Code (NDC), the highest quality ingredients and the game-changing CiBiDinol, Xceptol Pain Cream is a CBD product with industry-defining reliability and compliance. CannAssist believes Xceptol represents the next step for CBD products. CBD is a non-psychoactive compound found in hemp. To view the Company's products on RangeMe, visit https://app.rangeme.com/suppliers/xceptor-llc-07382a/brands/161478.   RangeMe is an online platform that enables retail buyers to efficiently discover consumer-ready, innovative and emerging products while empowering suppliers to manage and grow their brands with the tools, insights and services they need. Safe Harbor for Forward-Looking StatementsForward-looking statements are inherently subject to risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, the following: the timing and nature of any capital raising transactions; our ability to offer products and services for use by customers in existing and new markets; our ability to deliver in a timely fashion and to our customers' satisfaction the products purchased; the risk of competition; our ability to find, recruit and retain personnel with knowledge and experience in selling products and services in existing and new markets; our ability to manage growth; and general market, economic and business conditions. Additional factors that could cause actual results to differ materially from those anticipated by our forward-looking statements are under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year 2019 and our subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date hereof, and we expressly disclaim any obligation or undertaking to update forward-looking statements.For further information regarding the Company, please contact:     CannAssist International Corp.  855 South Mission Ave, Ste K 400  Fallbrook, CA 92028  Tel. (888)991-2196  www.cannassistinternational.com/investor-relationsCorporate Communications:  InvestorBrandNetwork (IBN)  Los Angeles, California  www.InvestorBrandNetwork.com  310.299.1717 Office  Editor@InvestorBrandNetwork.com

  • GlobeNewswire

    InvestorBrandNetwork (IBN) Coverage Initiated for CannAssist International Corp.

    NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CannAssist International Corp. (OTCQB: CNSC), a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand, today announces it has selected the corporate communications expertise of the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. CannAssist is the owner of Xceptor Labs, an R&D and raw material manufacturing outfit leveraging its proprietary CiBiDinol technology to create CBD products that it believes have better absorption than currently marketed oil-based products. CiBiDinol is believed to provide CBD in a format that is more in line with the body’s natural bioactivity. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life, while offering more predictable potency and enabling reduced dosage requirements.As part of the Client Partner relationship with CannAssist, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for CannAssist International Corp.“We are pleased to engage IBN to maximize our communication with existing and potential shareholders while refining our overall messaging and outreach,” states Mark Palumbo, CEO of CannAssist.With 15+ years of experience assisting 500+ client partners improve communications within the investment community, and a sizable family of 50\+ trusted brands, IBN has amassed a collective audience that includes millions of social media followers. IBN is uniquely positioned to provide CannAssist the solutions needed to reach a wide audience of investors, consumers, journalists and the general public.“The cannabidiol market has been on fire since the 2018 Farm Bill was signed into law. In 2018, the global CBD market was valued at $4.6 billion, and it’s forecast to reach $23.6 billion by 2025, according to Grand View Research. CannAssist is uniquely positioned to capitalize on this market growth,” states Chris Johnson, Director of Client Solutions for IBN. “Based on current revenue from raw material sales, retail sales and the Xceptol brand’s international distribution, CannAssist expects to reach first-year sales of $5 million. We’re excited to customize our comprehensive suite of corporate communications solutions for the company as it seeks to expand its product pipeline and achieve steady sales growth in the years ahead.”To learn more about CannAssist, visit the company's corporate newsroom profile at www.IBN.fm/CNSCAbout CannAssist International Corp.CannAssist produces and sells its cannabidiol (“CBD”) product, ‘CiBiDinol’, which is formulated based on a proprietary process developed by its founder, Mark Palumbo. CBD is a non-psychoactive compound found in hemp. CannAssist's initial research and development work, aimed at enhancing the bioavailability of desired molecular structures, resulted in the creation of a line of CBD products, most notably its CBD product, CiBiDinol. CiBiDinol will be available in a line of consumable and topical products that the company believes will make enhanced CBD products more available and accessible to consumers.For more information about the company, visit www.CannAssistInternational.com.About InvestorBrandNetwork The InvestorBrandNetwork (“IBN”) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of Client Partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.For more information on IBN visit https://www.InvestorBrandNetwork.comPlease see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/DisclaimerForward-Looking StatementsThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.Corporate CommunicationsInvestorBrandNetwork (IBN) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

Advertisement
Advertisement